BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6231394)

  • 1. [Fibrous dysplasia in the pterygiod process in postoperative breast cancer].
    Sakata T; Yamasaki K; Akagi H; Masui H; Takahashi H; Kurokawa A
    Rinsho Hoshasen; 1983 Nov; 28(12):1499-501. PubMed ID: 6231394
    [No Abstract]   [Full Text] [Related]  

  • 2. Scintigraphic evaluation of polyostotic fibrous dysplasia.
    Johns WD; Gupta SM; Kayani N
    Clin Nucl Med; 1987 Aug; 12(8):627-31. PubMed ID: 3665301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The solitary hand lesion: bone scintigraphy of monostotic fibrous dysplasia.
    Novetsky GJ; Berlin L
    Clin Nucl Med; 1984 Oct; 9(10):590. PubMed ID: 6237822
    [No Abstract]   [Full Text] [Related]  

  • 4. Radionuclide bone imaging as an aid in the diagnosis of fibrous dysplasia: report of case.
    Shuster HL; Sadowsky D; Friedman JM
    J Oral Surg; 1979 Apr; 37(4):267-70. PubMed ID: 285232
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrous dysplasia associated with primary hyperparathyroidism in the absence of the McCune-Albright syndrome: Tc-99m MIBI and Tc-99m MDP findings.
    Kim SJ; Seok JW; Kim IJ; Kim YK; Jung DS; Kim DS
    Clin Nucl Med; 2003 May; 28(5):416-8. PubMed ID: 12702945
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of bone scan in the diagnosis of Jaffé-Lichtenstein-Uehlinger syndrome.
    Chroustova D; Votruba M; Sprindrich J; Sosna B
    Nucl Med Rev Cent East Eur; 2004; 7(1):87-9. PubMed ID: 15318318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Criteria and quantification of fibrous dysplasia on MDP scanning.
    Sathekge MM; Clauss RP
    Nuklearmedizin; 1995 Dec; 34(6):229-31. PubMed ID: 8596739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of bone scan in the McCune-Albright syndrome. Report of a case.
    Edeburn GF; Mortensson W
    Acta Radiol Diagn (Stockh); 1986; 27(6):719-21. PubMed ID: 3812022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Whole body bone scintigram with 99mTc-HMDP (technetium-99m-hydroxy methylene diphosphonate) (author's transl)].
    Isobe Y; Ko S; Umegaki Y; Takahashi S; Kawaguchi N; Wada S; Matsumoto S
    Radioisotopes; 1981 Nov; 30(11):606-8. PubMed ID: 7335900
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bone scintigraphy of fibrous dysplasia (author's transl)].
    Ichiya Y; Watanabe K; Matsuura K; Eguchi M
    Rinsho Hoshasen; 1978 Aug; 23(8):899-900. PubMed ID: 691798
    [No Abstract]   [Full Text] [Related]  

  • 11. Normal technetium-99m-MDP uptake in fibrous dysplasia of the hip.
    Sood A; Raman R; Jhobta A; Dhiman DS; Seam RK
    Hell J Nucl Med; 2009; 12(1):72-3. PubMed ID: 19330193
    [No Abstract]   [Full Text] [Related]  

  • 12. [Abnormal accumulation of 99mTc-phosphorous compounds in the breast].
    Inoue Y; Shichijo S
    Rinsho Hoshasen; 1983 Aug; 28(8):845-9. PubMed ID: 6317921
    [No Abstract]   [Full Text] [Related]  

  • 13. [Early diagnosis of bone infarction in children with sickle cell anemia by MDP 99m Tc scanning].
    Koren A; Fedchteyn S; Katsuni E
    Harefuah; 1982 Mar; 102(5):182-5. PubMed ID: 6214460
    [No Abstract]   [Full Text] [Related]  

  • 14. Technetium - 99M methylene-diphosphonate bone scan: mechanisms and clinical applications.
    Tan KF; Chang CH
    Singapore Med J; 1982 Apr; 23(2):61-72. PubMed ID: 6215712
    [No Abstract]   [Full Text] [Related]  

  • 15. [Extraosseous accumulation of 99m-Tc-MDP--with special reference to intratumor accumulation].
    Yasuda E; Yoshida H; Ichikawa H; Matsuo S; Kimura T; Kanamori I; Nakano S; Watahiki H; Takeda I
    Rinsho Hoshasen; 1983 Aug; 28(8):851-7. PubMed ID: 6228679
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of tc-99m MDP, HMDP, and DPD with respect to bone-to-soft tissue ratios.
    Buell U; Kirsch CM; Kleinhans E; Jäger B
    J Nucl Med; 1983 Dec; 24(12):1201-2. PubMed ID: 6227711
    [No Abstract]   [Full Text] [Related]  

  • 17. [Basic and clinical studies of 99mTc-hydroxymethylene diphosphonate for skeletal imaging agent].
    Ishine M; Kawamura M; Koizumi M; Itoh H; Murase K; Inatsuki S; Iio A; Hamamoto K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1982 Apr; 42(4):389-97. PubMed ID: 6214765
    [No Abstract]   [Full Text] [Related]  

  • 18. Value of pre-treatment and follow-up skeletal scintigraphy in operable breast cancer.
    Pauwels EK; Heslinga JM; Zwaveling A
    Clin Oncol; 1982 Mar; 8(1):25-32. PubMed ID: 6280915
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical evaluation of bone scintigraphy with 99mTc-HMDP (author's transl)].
    Ishii C; Mori Y; Hata Y; Katsuyama N; Fujioka M; Fukazawa W; Hashimoto H; Horiuchi T; Fujioka M; Kawakami K
    Radioisotopes; 1981 Jul; 30(7):401-3. PubMed ID: 7323328
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased skeletal:renal uptake ratio: etiology and characteristics.
    Cheng TH; Holman BL
    Radiology; 1980 Aug; 136(2):455-9. PubMed ID: 6447313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.